China Resources Medical Holdings Company Limited (1515.HK)
HKD 3.97
(-0.5%)
HKD 3.97
(-0.5%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.19 Billion | 626.58 Million | 710.43 Million | 643.68 Million | 366.05 Million | 334.14 Million |
| Net Income | 492.92 Million | 138.97 Million | 417.91 Million | 310.13 Million | 390.86 Million | 430.89 Million |
| Depreciation & Amortization | 610.86 Million | 332.48 Million | 182.87 Million | 113.38 Million | 63.64 Million | 69.61 Million |
| Deferred income taxes | - | -171.15 Million | -141.78 Million | -66.52 Million | 94.78 Million | 210.34 Million |
| Stock-based compensation | - | 2.16 Million | 10.11 Million | 8.72 Million | 13.08 Million | -5.31 Million |
| Change in working capital | -313.31 Million | 168.99 Million | 131.67 Million | 57.8 Million | -107.86 Million | -205.03 Million |
| Other non-cash items | 31.22 Million | 155.12 Million | 109.63 Million | 220.17 Million | -88.45 Million | -166.36 Million |
| Investing Cash Flow | -2.62 Billion | 57.34 Million | -1.93 Billion | 60.36 Million | 157.23 Million | 355.42 Million |
| Investments in PPE | -486.68 Million | -252.86 Million | -198.43 Million | -209.54 Million | -36.36 Million | -57.6 Million |
| Acquisitions | -3.76 Billion | 169.02 Million | -1.53 Billion | 42.17 Million | 23.31 Million | 5.48 Million |
| Investment purchases | -2.68 Billion | -4.37 Billion | -4.47 Billion | -6.7 Billion | -5.68 Billion | -4.85 Billion |
| Sales/Maturities of investments | 3.56 Billion | 4.49 Billion | 4.27 Billion | 6.92 Billion | 5.84 Billion | 5.23 Billion |
| Other Investing Activities | -16.63 Million | 26.48 Million | 3.52 Million | 3.84 Million | 13.25 Million | 20.51 Million |
| Financing Cash Flow | -437.08 Million | -33.16 Million | 845.95 Million | -7.38 Million | -40.96 Million | -44.71 Million |
| Debt repayment | -218.81 Million | -8.42 Billion | -5.1 Billion | -8.68 Million | -2.73 Million | - |
| Dividends payments | -42.35 Million | -129.6 Million | -91.07 Million | -115.09 Million | -131.48 Million | -118.56 Million |
| Common Stock Repurchased | - | - | - | 8.3 Million | -40.25 Million | -213.94 Million |
| Common Stock Issuance | - | - | - | 380 Thousand | 42.98 Million | - |
| Other Financing Activities | -129.44 Million | 8.51 Billion | 6.04 Billion | 107.71 Million | 90.52 Million | 287.79 Million |
| Accounts receivables | -111.25 Million | 155.96 Million | 131.46 Million | 81.09 Million | -123.62 Million | -167.74 Million |
| Accounts payables | - | -7.45 Million | -49.56 Million | -159.59 Million | -19.5 Million | - |
| Inventory | 65.18 Million | 13.02 Million | 211 Thousand | -23.29 Million | 15.76 Million | -37.28 Million |
| Other working capital | -294.16 Million | 7.45 Million | 49.56 Million | 159.59 Million | 19.5 Million | 116.84 Million |
| Cash at beginning of period | 3.1 Billion | 2.32 Billion | 2.7 Billion | 2 Billion | 1.52 Billion | 877.05 Million |
| Cash at end of period | 1.23 Billion | 2.97 Billion | 2.32 Billion | 2.7 Billion | 2 Billion | 1.52 Billion |
| Capital Expenditure | -486.68 Million | -252.86 Million | -198.43 Million | -209.54 Million | -36.36 Million | -57.6 Million |
| Effect of forex changes on cash | 141 Thousand | 2.73 Million | 2.34 Million | -1.52 Million | -281 Thousand | 2.27 Million |
| Net cash flow / Change in cash | -1.86 Billion | 653.49 Million | -377.31 Million | 695.15 Million | 482.04 Million | 647.12 Million |
| Free Cash Flow | 708.44 Million | 373.71 Million | 511.99 Million | 434.14 Million | 329.68 Million | 276.53 Million |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 433.94 Million | -139.99 Million | 492.92 Million | 397.67 Million | 138.97 Million | 21.18 Million |
| Depreciation & Amortization | 302.72 Million | 321.41 Million | 610.86 Million | 289.44 Million | 332.48 Million | 298.34 Million |
| Deferred income taxes | - | - | - | - | -171.15 Million | -168.92 Million |
| Stock-based compensation | - | - | - | - | 2.16 Million | -65 Thousand |
| Change in working capital | - | -340.23 Million | -313.31 Million | - | 168.99 Million | 56.43 Million |
| Other non-cash items | -228.9 Million | 813.5 Million | 31.22 Million | -146.68 Million | 155.12 Million | 391.08 Million |
| Investing Cash Flow | -261.28 Million | -3.02 Billion | -2.62 Billion | 398.7 Million | 57.34 Million | -501.24 Million |
| Investments in PPE | -248.39 Million | -292.98 Million | -486.68 Million | -193.69 Million | -252.86 Million | -357.59 Million |
| Acquisitions | - | -3.76 Billion | -3.76 Billion | - | 169.02 Million | - |
| Investment purchases | - | - | -2.68 Billion | - | -4.37 Billion | - |
| Sales/Maturities of investments | - | - | 3.56 Billion | - | 4.49 Billion | - |
| Other Investing Activities | -12.89 Million | 1.04 Billion | -16.63 Million | 592.39 Million | 26.48 Million | -143.65 Million |
| Financing Cash Flow | -192.26 Million | -400.57 Million | -437.08 Million | -36.5 Million | -33.16 Million | -179.4 Million |
| Debt repayment | -161.38 Million | - | -218.81 Million | -29.85 Million | -8.42 Billion | - |
| Dividends payments | - | -42.35 Million | -42.35 Million | - | -129.6 Million | -129.6 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -30.88 Million | -358.22 Million | -129.44 Million | -66.35 Million | 8.51 Billion | -49.8 Million |
| Accounts receivables | - | -111.25 Million | -111.25 Million | - | 155.96 Million | 109.17 Million |
| Accounts payables | - | - | - | - | -7.45 Million | - |
| Inventory | - | 65.18 Million | 65.18 Million | - | 13.02 Million | -17.33 Million |
| Other working capital | - | -294.16 Million | -294.16 Million | - | 7.45 Million | -35.4 Million |
| Cash at beginning of period | 1.23 Billion | 4 Billion | 3.1 Billion | 3.1 Billion | 2.32 Billion | 3.01 Billion |
| Cash at end of period | 1.29 Billion | 4 Billion | 1.23 Billion | 4 Billion | 2.97 Billion | 3.64 Billion |
| Capital Expenditure | -248.39 Million | -292.98 Million | -486.68 Million | -193.69 Million | -252.86 Million | -357.59 Million |
| Effect of forex changes on cash | 183 Thousand | -557 Thousand | 141 Thousand | 698 Thousand | 2.73 Million | 989 Thousand |
| Net cash flow / Change in cash | 54.39 Million | - | -1.86 Billion | 903.33 Million | 653.49 Million | 634.09 Million |
| Free Cash Flow | 259.37 Million | 361.69 Million | 708.44 Million | 346.74 Million | 373.71 Million | 409.39 Million |
AMLX
5956
600202
TRMK
5759
AWR